Prevalence of Performance-Enhancing Substance Use and Associated Factors among Portuguese Gym/Fitness Users

References

• Al-Falasi, O., Al-Dahmani, K., Al-Eisaei, K., Al-Ameri, S., Al-Maskari, F., Nagelkerke, N., & Schneider, J. (2009). Knowledge, attitude and practice of anabolic steroids use among gym users in Al-Ain district, United Arab Emirates. The Open Sports Medicine Journal, 2(1), 75–81. doi:10.2174/1874387000802010075
   Google Scholar
• Allahverdipour, H., Jalilian, F., & Shaghaghi, A. (2012). Vulnerability and the intention to anabolic steroids use among Iranian gym users: An application of the theory of planned behavior. Substance Use & Misuse, 47(3), 309–317. doi:10.3109/10826084.2011.633296
   PubMed Web of Science ®Google Scholar
• Backhouse, S., Collins, C., Defoort, Y., McNamee, M., Parkinson, A., & Sauer, M. (2014). Study on doping prevention - A map of legal, regulatory and prevention practice provisions in EU 28. Project report. Luxembourg: European Commission.
   Google Scholar
• Backhouse, S., Whitaker, L., & Mckenna, J. (2015). Social psychology of doping in sport: a mixed-studies narrative synthesis. Project Report. Montreal Canada: World Anti-Doping Agency.
   Google Scholar
• Baker, J. S., Graham, M. R., & Davies, B. (2006). Steroid and prescription medicine abuse in the health and fitness community: A regional study. European Journal of Internal Medicine, 17(7), 479–484. doi:10.1016/j.ejim.2006.04.010
   PubMed Web of Science ®Google Scholar
• Baron, D. A., Martin, D. M., & Magd, S. A. (2007). Doping in sports and its spread to at-risk populations: An international review. World Psychiatry, 6(2), 118–123.
   PubMed Web of Science ®Google Scholar
• Bergsgard, N. A., Tangen, J. O., Barland, B., & Breivik, G. (1996). Doping in Norwegian gyms - a big problem?. International Review for the Sociology of Sport, 31(4), 351–364. doi:10.1177/101269029603100401
   Google Scholar
• Brennan, R., Wells, J. S. G., & Van Hout, M. C. (2017). The injecting use of image and performance-enhancing drugs (IPED) in the general population: A systematic review. Health & Social Care in the Community, 25(5), 1459–1531. doi:10.1111/hsc.12326
   PubMed Web of Science ®Google Scholar
• EHFA (The European Health and Fitness Association). (2011). Fitness against doping: Interim report. Brussels: Author.
   Google Scholar
• Glaziou, P. (2017). Sample size for a prevalence survey, with finite population correction. Sampsize.sourceforge.net. Retrieved from http://sampsize.sourceforge.net/iface/index.html#prev
   Google Scholar
• Haerinejad, M. J., Ostovar, A., Farzaneh, M. R., & Keshavarz, M. (2016). The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian Journal of Sports Medicine, 7(3), 1–8. doi:10.5812/asjsm.35018
   PubMedGoogle Scholar
• Ip, E. J., Barnett, M. J., Tenerowicz, M. J., & Perry, P. J. (2011). The anabolic 500 survey: Characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy, 31(8), 757–766. doi:10.1592/phco.31.8.757
   PubMed Web of Science ®Google Scholar
• Ip, E. J., Trinh, K., Tenerowicz, M. J., Pal, J., Lindfelt, T. A., & Perry, P. J. (2015). Characteristics and behaviors of older male anabolic steroid users. Journal of Pharmacy Practice, 28(5), 450–456. doi:10.1177/0897190014527319
   PubMedGoogle Scholar
• Korkia, P. I., & Stimson, C. V. (1997). lndications of prevalence, practice and effects of anabolic steroid use in Great Britain. International Journal of Sports Medicine, 18, 557–562. doi:10.1055/s-2007-972681
   PubMed Web of Science ®Google Scholar
• Krantz, J. H., & Dalal, R. (2000, December). Validity of web-based psychological research. In M. H. Birnbaum (Ed.), Psychological experiments on the internet (pp. 35–60). San Diego, CA: Academic Press.doi:10.1016/B978-012099980-4/50003-4
   Google Scholar
• Lazuras, L. (2017, March 20). Doping in sport: Drug use ‘fast becoming a crisis’ [interview]. BBC.com. Retrieved from https://www.bbc.com/sport/38884801
   Google Scholar
• Lentillon-Kaestner, V., & Ohl, F. (2011). Can we measure accurately the prevalence of doping?. Scandinavian Journal of Medicine & Science in Sports, 21(6), e132–e142. doi:10.1111/j.1600-0838.2010.01199.x
   PubMed Web of Science ®Google Scholar
• Massada, M., Ribeiro, S., & Ferreira, V. (2011). Consumo de substâncias dopantes no desporto recreativo português – um estudo em praticantes de musculação [Consumption of doping substances in Portuguese recreational sports – a study of bodybuilders]. Rev. Medicina Desportiva Informa, 2(4), 19–21.
   Google Scholar
• McCabe, S. E. (2004). Comparison of web and mail surveys in collecting illicit drug use data: A randomized experiment. Journal of Drug Education, 34(1), 61–72. doi:10.2190/4HEY-VWXL-DVR3-HAKV
   PubMed Web of Science ®Google Scholar
• Molero, Y., Bakshi, A. S., & Gripenberg, J. (2017). Illicit drug use among gym-goers: A cross-sectional study of gym-goers in Sweden. Sports Medicine - Open, 31(3), 1–8. doi:10.1186/s40798-017-0098-8
   Google Scholar
• Mougios, V. (2002). Doping abuse in recreational sports. In C. Peters, T. Schulz, & H. Michna (Eds.), Biomedical side effects of doping (pp. 101–104). Köln: Verlag SPORT und BUCH Strauß.
   Google Scholar
• Nicos, K., Constantinos, P., Stavros, P., Michael, P., & Christina, L. (2008). The use of anabolic steroids and other prohibited substances by gym enthusiasts in Cyprus. International Review for the Sociology of Sport, 43(3), 271–287.
   Web of Science ®Google Scholar
• Ntoumanis, N., Ng, J., Barkoukis, V., & Backhouse, S. (2013). A statistical synthesis of the literature on personal and situational variables that predict doping in physical activity settings. Project Report. World Anti-Doping Agency. Retrieved from World Anti-doping agency website https://www.wadaama.org/sites/default/files/resources/files/2012%20funded%20-%20Ntoumanis%20-%20final%20report%20%28Statistical%20synthesis%29.pdf
   Google Scholar
• Parkinson, A. B., & Evans, N. A. (2005). Anabolic androgenic steroids: A survey of 500 users. Medicine & Science in Sports & Exercise, 38(4), 644–651. doi:10.1249/01.mss.0000210194.56834.5d
   Web of Science ®Google Scholar
• Pedersen, I. K. (2010). Doping and the perfect body expert: Social and cultural indicators of performance-enhancing drug use in Danish gyms. Sport in Society, 13(3), 503–516. doi:10.1080/17430431003588184
   Google Scholar
• Pedragosa, V., & Cardadeiro, E. (2018). Relatório final: barómetro do fitness em Portugal 2018 [Final report: fitness barometer in Portugal 2018]. Lisboa: Centro de Estudos Económicos e Institucionais. Retrieved from https://www.portugalactivo.pt/sites/default/files/documentos_publicos/barometro_do_fitness_em_portugal_2018.pdf
   Google Scholar
• Pope, H. G. J., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014). Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement. Endocrine Reviews, 35(3), 341–375. doi:10.1210/er.2013-1058
   PubMed Web of Science ®Google Scholar
• Sagoe, D., & Pallesen, S. (2018). Androgen abuse epidemiology. Current Opinion in Endocrinology & Diabetes and Obesity, 25(3), 185–194. doi:10.1097/MED.0000000000000403
   PubMedGoogle Scholar
• Santos, A. M., Rocha, M. S. P. D., & Silva, M. F. D. (2011). Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders. Substance Use & Misuse, 46(6), 742–748. doi:10.3109/10826084.2010.534123
   PubMed Web of Science ®Google Scholar
• Sekulic, D., Tahiraj, E., Zvan, M., Zenic, N., Uljevic, O., & Lesnik, B. (2016). Doping attitudes and covariates of potential doping behaviour in high-level team-sport athletes; gender specific analysis. Journal of Sports Science & Medicine, 15(4), 606–615.
   PubMed Web of Science ®Google Scholar
• Silva, L. S. M., & Moreau, R. L. (2003). Use of anabolic-androgenic steroids among body builders in major gym centers in São Paulo. Brazil. Brazilian Journal of Pharmaceutical Sciences, 39(3), 327–333.
   Google Scholar
• Smith, G. (2008). Does gender influence online survey participation? A record-linkage analysis of university faculty online survey response behavior. ERIC document reproduction service No. ED 501717. Retrieved from http://scholarworks.sjsu.edu/cgi/viewcontent.cgi?article=1003&context=elementary_ed_pub
   Google Scholar
• Striegel, H., Simon, P., Frisch, S., Roecker, K., Dietz, K., Dickhuth, H.-H., & Ulrich, R. (2006). Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system. Drug and Alcohol Dependence, 81(1), 11–19. doi:10.1016/j.drugalcdep.2005.05.013
   PubMed Web of Science ®Google Scholar
• Tahtamouni, L. H., Mustafa, N. H., Alfaouri, A. A., Hassan, I. M., Abdalla, M. Y., & Yasin, S. R. (2008). Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes. The European Journal of Public Health, 18(6), 661–665. doi:10.1093/eurpub/ckn062
   PubMed Web of Science ®Google Scholar
• Tavares, A. S., Serpa, S., Horta, L., & Rosado, A. (2019). Psychosocial factors and performance enhancing substances in gym users: A systematic review. Revista de Psicologia Del Deporte/Journal of Sport Psychology, 28(1), 131–142.
   Web of Science ®Google Scholar
• Wazaify, M., Bdair, A., Al-Hadidi, K., & Scott, J. (2014). Doping in gymnasiums in Amman: The other side of prescription and nonprescription drug abuse. Substance Use & Misuse, 49(10), 1296–1302. doi:10.3109/10826084.2014.891625
   PubMed Web of Science ®Google Scholar
• World Anti-Doping Agency. (2018). 2016 Anti-doping rule violations (ADRVs) report. Retrieved from WADA website https://www.wadaama.org/sites/…/2016_adrvs_report_web_release_april_2018_0.pdf
   Google Scholar